癌症诊断的延迟:欧洲的挑战和机遇
Cristina Renzi1, Stefano Odelli2, Federica Morani3
1. renzi.cristina@hsr.it.
Acta bio-medica : Atenei Parmensis
|September 11, 2023
概括
癌症诊断的延迟和护理不平等仍然存在,尤其影响弱势群体. 解决多病症和利用康复计划等因素是改善癌症结果的关键.
科学领域:
- 公共卫生 公共卫生
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 早期癌症诊断是全球卫生优先事项,但许多患者面临着晚期疾病诊断或紧急呈现.
- 显著的诊断延迟和护理不平等甚至存在于普遍医疗保健系统中.
研究的目的:
- 检查导致诊断延迟和癌症护理不平等的因素.
- 讨论改善癌症诊断的挑战和机会.
主要方法:
- 进行了批判性文献综述.
- 该审查侧重于2019-2023年期间在欧洲发表的研究,特别强调意大利.
主要成果:
- 欧洲各国在癌症查,诊断和治疗方面的差异明显,影响了特定的人口子组.
- 意大利的区域查参与率差异很大 (例如,北方与南方).
- 高龄,多病症和先前存在的心理健康状况与诊断延迟有关;COVID-19加剧了现有的不平等.
结论:
- 了解身体和精神健康疾病如何影响癌症诊断对于公平护理至关重要.
- 欧盟和国家复苏计划提供了减少不平等的机会,并加强对老年人口的癌症护理和慢性疾病管理.
更多相关视频
相关概念视频
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


